Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance

Journal of Clinical Oncology

Volumn 33, Issue 1, 2015, Pages 51-57

  Kollmannsberger, Christian ^a   Tandstad, Torgrim ^c   Bedard, Philippe L ^b   Cohn Cedermark, Gabriella ^d   Chung, Peter W ^b   Jewett, Michael A ^b   Powles, Tom ^e   Warde, Padraig R ^d   Daneshmand, Siamak ^g   Protheroe, Andrew ^f   Tyldesley, Scott ^a   Black, Peter C ^a   Chi, Kim ^a   So, Alan I ^a   Moore, Malcom J ^b   Nichols, Craig R ^h  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d KAROLINSKA INSTITUTE   (Sweden)

^e ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE DURATION; DISEASE SPECIFIC SURVIVAL; HEALTH SURVEY; HUMAN; HUMAN TISSUE; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; ORCHIECTOMY; RETROSPECTIVE STUDY; SEMINOMA; TESTIS CANCER; TREATMENT OUTCOME; TUMOR INVASION; FOLLOW UP; KAPLAN MEIER METHOD; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOLOGY; PROCEDURES; PROGNOSIS; STATISTICS AND NUMERICAL DATA; TESTICULAR NEOPLASMS; TIME; TUMOR RECURRENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORCHIECTOMY; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RETROSPECTIVE STUDIES; SEMINOMA; TESTICULAR NEOPLASMS; TIME FACTORS; YOUNG ADULT;

EID: 84920626972     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.56.2116     Document Type: Article

References (22)

1. Sonneveld DJ, Hoekstra HJ, Van Der Graaf WT, et al.: The changing distribution of stage in nonseminomatous testicular germ cell tumours, from 1977 to 1996. BJU Int 84:68-74, 1999
2. Powles TB, Bhardwa J, Shamash J., et al.: The changing presentation of germ cell tumours of the testis between 1983 and 2002. BJU Int 95:1197-1200, 2005
3. Groll RJ, Warde P, Jewett MA: A comprehensive systematic review of testicular germ cell tumor surveillance. Crit Rev Oncol Hematol 64:182-197, 2007
4. Read G, Stenning SP, Cullen M.H., et al.: Medical Research Council prospective study of surveillance for stage I testicular teratoma: Medical Research Council Testicular Tumors Working Party. J Clin Oncol 10:1762-1768, 1992
5. Tandstad T, Dahl O, Cohn-Cedermark G, et al.: Risk-adapted treatment in clinical stage I nonseminoma-tous germ cell testicular cancer: The SWENOTECA management program. J Clin Oncol 27:2122-2128, 2009
6. Kollmannsberger C, Moore C, Chi K.N., et al.: Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: Diminishing treatment-related morbidity while maintaining efficacy. Ann Oncol 21:1296-1301, 2010
7. Albers P, Albrecht W, Algaba F., et al.: Guidelines on testicular cancer. European Association of Urology 2011 http://www.uroweb.org/gls/pdf/10-Testicular-Cancer.pdf
8. Wood L, Kollmannsberger C, Jewett M., et al.: Canadian consensus guidelines for the management of testicular germ cell cancer. Can Urol Assoc J 4:e19-e38, 2010
9. Krege S, Beyer J, Souchon R., et al.: European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG)-Part I. Eur Urol 53:478-496, 2008
10. Jeldres C, Nichols C, Pham K., et al.: United States trends in patterns of care in clinical stage I testicular cancer: Results from the National Cancer Database (1998-2011). J Clin Oncol 32:5s, 2014 (suppl; abstr 4519)
11. Vergouwe Y, Steyerberg EW, Eijkemans M.J., et al.: Predictors of occult metastasis in clinical stage I nonseminoma: A systematic review. J Clin Oncol 21:4092-4099, 2003
12. Klepp O, Olsson AM, Henrikson H, et al.: Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: Multivariate analysis of a prospective multicenter study: Swedish-Norwegian Testicular Cancer Group. J Clin Oncol 8:509-518, 1990
13. Albers P, Siener R, Kliesch S., et al.: Risk factors for relapse in clinical stage I nonseminoma-tous testicular germ cell tumors: Results of the German Testicular Cancer Study Group Trial. J Clin Oncol 21:1505-1512, 2003
14. The International Germ Cell Cancer Collaborative Group: International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers-International Germ Cell Cancer Collaborative Group. J Clin Oncol 15:594-603, 1997
15. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. Am J Stat Assoc 53:457-481, 1958
16. Tolan S, Vesprini D, Jewett M.A., et al.: No role for routine chest radiography in stage I seminoma surveillance. Eur Urol 57:474-479, 2010
17. Rustin GJ, Mead GM, Stenning S.P., et al.: Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminoma-tous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197-The National Cancer Research Institute Testis Cancer Clinical Studies Group. J Clin Oncol 25:1310-1315, 2007
18. Chung P, Mayhew LA, Warde P, et al.: Management of stage I seminomatous testicular cancer: A systematic review. Clin Oncol (R Coll Radiol) 22:6-16, 2010
19. Chung PW, O'Malley M, Jewett MA, et al.: Evaluation of low-dose CT scans for surveillance in stage I testicular cancer. J Clin Oncol 29:305s (suppl; abstr 4565), 2011
20. Sharp DS, Carver BS, Eggener S.E., et al.: Clinical outcome and predictors of survival in late relapse of germ cell tumor. J Clin Oncol 26:5524-5529, 2008
21. Daugaard G, Petersen PM, Rorth M: Surveillance in stage I testicular cancer. Apmis 111:76-83, 2003
22. Ackers C, Rustin GJ: Lactate dehydrogenase is not a useful marker for relapse in patients on surveillance for stage I germ cell tumours. Br J Cancer 94:1231-1232, 2006